MENU
+Compare
NTRA
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$162.31
Change
-$5.88 (-3.50%)
Capitalization
11.04B

NTRA Natera Forecast, Technical & Fundamental Analysis

a genetic testing company which develops proprietary bioinformatics-based technology

NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NTRA with price predictions
Feb 21, 2025

NTRA in downward trend: price dove below 50-day moving average on February 20, 2025

NTRA moved below its 50-day moving average on February 20, 2025 date and that indicates a change from an upward trend to a downward trend. In of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRA as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on February 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

NTRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 315 cases where NTRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.684) is normal, around the industry mean (23.448). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.881) is also within normal values, averaging (41.230).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NTRA is expected to report earnings to rise 88.50% to -49 cents per share on February 27

Natera NTRA Stock Earnings Reports
Q4'24
Est.
$-0.49
Q3'24
Beat
by $0.31
Q2'24
Beat
by $0.39
Q1'24
Beat
by $0.15
Q4'23
Beat
by $0.12
The last earnings report on November 12 showed earnings per share of -25 cents, beating the estimate of -56 cents. With 1.61M shares outstanding, the current market capitalization sits at 11.04B.
A.I. Advisor
published General Information

General Information

a genetic testing company which develops proprietary bioinformatics-based technology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13011 McCallen Pass
Phone
+1 650 980-9190
Employees
3018
Web
https://www.natera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UNIY48.550.29
+0.61%
WisdomTree Voya Yld Enh USD Unvsl Bd Fd
MARB19.99-0.01
-0.07%
First Trust Merger Arbitrage ETF
VNQ91.64-0.91
-0.98%
Vanguard Real Estate ETF
AGOX28.19-0.50
-1.74%
Adaptive Alpha Opportunities ETF
AMID33.35-0.81
-2.37%
Argent Mid Cap ETF

NTRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-3.50%
ISRG - NTRA
42%
Loosely correlated
-2.44%
VCYT - NTRA
40%
Loosely correlated
-4.56%
CDNA - NTRA
39%
Loosely correlated
-4.66%
RDNT - NTRA
39%
Loosely correlated
-5.11%
GH - NTRA
36%
Loosely correlated
-9.56%
More